Iron chelation in the treatment of cancer: a new role for deferasirox? - Wikidata - wikimedia - TriplyDB

Iron chelation in the treatment of cancer: a new role for deferasirox?

Iron chelation in the treatment of cancer: a new role for deferasirox?

http://www.wikidata.org/entity/Q38112400

about

Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.Alginate-Iron Speciation and Its Effect on In Vitro Cellular Iron Metabolism Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cells.A comparative study of the iron status of patients with oesophageal adenocarcinoma to determine suitability for a clinical trial of iron chelation therapy.Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.New developments and controversies in iron metabolism and iron chelation therapy.Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells.Anti-leukemic properties of deferasirox via apoptosis in murine leukemia cell lines.Iron-induced parafibrin formation in tumors fosters immune evasion.A new salicylate synthase AmS is identified for siderophores biosynthesis in Amycolatopsis methanolica 239(T).A single-wavelength-emitting ratiometric probe based on phototriggered fluorescence switching of graphene quantum dots.High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines.The role of oxidative stress in activity of anticancer thiosemicarbazones.

P2860

Q26863390-B9981C66-3A5F-4AE3-8526-97C957415560 Q30399669-126FF912-9CA9-469E-9010-665E00C16856 Q35778343-8F9DD9E4-4BEA-4B55-8F16-1E812ECA124F Q35911202-E23A2A7A-0740-4390-B724-9461B16D01B7 Q36071604-C44ABB97-5382-4AAC-AD4D-BCF1BB28D685 Q36119319-676B2475-6528-4DC1-B5D4-293C3A88EF31 Q36719376-8647833B-277B-4F9A-8609-55D852F02FCF Q38710822-E066CBDC-98FE-4936-870A-1DF132CD708A Q38892236-A6549985-C30C-402A-8143-02E0D418ECBA Q40877330-989C97B5-7B26-4607-9414-D48AE2EC4197 Q41585809-1B8FA636-3EB6-4C28-AAED-253C04FCDF8E Q48829880-D12593A1-BD57-481C-8D88-61BCFB0BC3CE Q51737021-F05554EF-BF4E-4412-BD62-EC936D5A6DE0 Q52715779-BA5BDBE3-3FF7-4CEE-AD26-4E1691A76613

P2860

Iron chelation in the treatment of cancer: a new role for deferasirox?

http://www.wikidata.org/entity/Q38112400

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Iron chelation in the treatment of cancer: a new role for deferasirox?

@en

type

label

Iron chelation in the treatment of cancer: a new role for deferasirox?

@en

prefLabel

Iron chelation in the treatment of cancer: a new role for deferasirox?

@en

P1433

Q38112400-B94A1D9B-2CFD-4570-93F8-214589513BE3

P1476

Q38112400-19EA31ED-DF32-4F1B-8718-1D0E38379E21

P2093

Q38112400-3C04FB9B-2AB7-429A-AD60-4CA23677DB83

Q38112400-93B86E3B-CB2D-4E48-941E-9E232CB0C3CA

Q38112400-B219F774-B014-4246-AFED-6713A4A81111

Q38112400-E1879273-1FC4-4560-A3CE-BD25BF3C0F8D

Q38112400-E298C957-FB43-4978-9D6F-E9F81FC2869E

P2860

Q38112400-0390EC9C-7B8E-4D09-9C76-A0BDAF015F30

Q38112400-05B1CFAA-67B6-48C4-9D96-B6F985CE84F9

Q38112400-0A8A7AA9-0098-46C8-835B-D7B4EF26E5FB

Q38112400-0DFD2CEB-7499-4E02-993E-6C0B3F1A6296

Q38112400-17EBF297-6C96-42D2-AAED-FB5CD43D3D87

Q38112400-18BEB019-DB26-48EF-AB17-C4DD087127F1

Q38112400-1FBDBDC0-A9D5-4337-81FD-DFE85B33590A

Q38112400-3AFA6151-DD68-4A5F-949B-BD3EB0A331EB

Q38112400-3BE83C9A-EDC7-4587-90CD-A6952C99D7C6

Q38112400-3CED9507-786A-4ACF-9A51-3DBD375008C8

P304

Q38112400-35F674AF-5764-49E6-A624-B61DFAEF0938

P31

Q38112400-6ADACDE3-41BA-4431-B94B-F42D7073FD53

P356

Q38112400-2140260B-183D-4522-B3F8-152E4BDF46CC

P433

Q38112400-CABA85FF-7EB8-4664-A006-4D532C869170

P478

Q38112400-CB99B021-6FA6-4EF2-B50B-2DB710A345B0

P577

Q38112400-3FA0236C-0D6C-4F72-9EC7-954C851447CC

P698

Q38112400-0ECC7736-A8E9-4437-A83F-1E32FC9BA587

P356

P1433

The Journal of Clinical Pharmacology

P1476

Iron chelation in the treatment of cancer: a new role for deferasirox?

@en

P2093

Chris Tselepis

http://www.w3.org/2001/XMLSchema#string

Matthew R Bedford

http://www.w3.org/2001/XMLSchema#string

Richard D Horniblow

http://www.w3.org/2001/XMLSchema#string

Samuel J Ford

http://www.w3.org/2001/XMLSchema#string

Tariq H Iqbal

http://www.w3.org/2001/XMLSchema#string

P2860

Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal

mTOR and cancer therapy

Human ICE/CED-3 protease nomenclature

Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen

Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis

Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma.

Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging

Iron availability increases the pathogenic potential of Salmonella typhimurium and other enteric pathogens at the intestinal epithelial interface.

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial.

Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.

P304

885-891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.113

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23740857

http://www.w3.org/2001/XMLSchema#string